Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1986-4-2
|
pubmed:abstractText |
An 8-week therapy with cyclophosphamide (CP) and alternate-day prednisone was given to 65 patients having steroid-sensitive, frequently relapsing nephrotic syndrome, including 17 with steroid dependence. It induced remissions of less than 6 months in 18 patients, 6 to 36 months in 21 and over 3 years in 26. Considering a remission of 6 months as significant, certain clinical variables were compared in patients without such a response with those getting longer remissions. In the group with frequent relapses a higher proportion of patients aged above 8 years had remissions of over 6 months as well as over 3 years, than those who were younger at CP therapy. Among patients with frequent relapses as well as those with steroid dependence, a post-CP remission of more than 6 months was associated with a better long-term course. The response to CP in both groups was similar regarding the duration of remissions, but a greater proportion of steroid-dependent patients subsequently again showed steroid dependence or frequent relapses. Our findings suggest that a higher age at CP therapy and an ensuing remission of over 6 months are predictors of a better response, and steroid dependence of a less favorable outcome.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0391-6510
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
245-50
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4093243-Adrenal Cortex Hormones,
pubmed-meshheading:4093243-Age Factors,
pubmed-meshheading:4093243-Child,
pubmed-meshheading:4093243-Child, Preschool,
pubmed-meshheading:4093243-Cyclophosphamide,
pubmed-meshheading:4093243-Drug Therapy, Combination,
pubmed-meshheading:4093243-Female,
pubmed-meshheading:4093243-Follow-Up Studies,
pubmed-meshheading:4093243-Humans,
pubmed-meshheading:4093243-Male,
pubmed-meshheading:4093243-Nephrotic Syndrome,
pubmed-meshheading:4093243-Prednisone,
pubmed-meshheading:4093243-Recurrence,
pubmed-meshheading:4093243-Time Factors
|
pubmed:articleTitle |
Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence.
|
pubmed:publicationType |
Journal Article
|